| Name | Title | Contact Details |
|---|---|---|
Mark Charbonneau |
Vice President, Research and Development | Profile |
Gerardo Toledo |
Chief Executive Officer and Co Founder | Profile |
onramp 113 is a Dixon, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
IsoPlexis is leading a new era of functional proteomics. By identifying our most proteomically active single cells (or "superhero cells") for the first time, IsoPlexis enables researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at the majority of leading U.S. comprehensive cancer centers.
Shenandoah Biotechnology is a Warminster, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs.